Clinical Trials in Pittsburgh

Showing 20221-20240 of 21,047 trials

Therapy With Abraxane and 5-Fluorouracil, Epirubicin, Cyclophosphamide (FEC) for Patients With Breast Cancer

NCT00110695

The purpose of this study is to learn how breast cancer tumors respond to a drug called Abraxane followed by a combination of 3 chemotherapy drugs commonly used for breast cancer.

Breast Neoplasms

NSABP Foundation Inc66 participantsStarted Apr 2005

Pittsburgh, Pennsylvania, United States

COMPLETEDPhase 1/2< 1 mile

The LIFE Study: Lifestyle Interventions and Independence for Elders, Pilot

NCT00116194

The purpose of this study is to gather preliminary data that will determine the feasibility of conducting a Phase III, randomized, controlled trial (RCT) that will provide definite evidence in the use of physical exercise to prevent mobility disability in older persons.

Physically ChallengedAging

National Institute on Aging (NIA)424 participantsStarted Apr 2004

Palo Alto, California, United States • Winston-Salem, North Carolina, United States • Pittsburgh, Pennsylvania, United States +1 more locations

COMPLETEDPhase 3< 1 mile

An Evaluation of Treatment of Amblyopia in Children 7 To <18 Years Old

NCT00094692

The goals of this study are: * To determine the response rate of treatment of amblyopia in 7 to \<18 year olds. * To determine the frequency of recurrence of amblyopia in 7 to \<18 year olds after discontinuation of amblyopia treatment.

Amblyopia

Jaeb Center for Health Research507 participantsStarted Oct 2002

Baltimore, Maryland, United States • Philadelphia, Pennsylvania, United States • Pittsburgh, Pennsylvania, United States

Therapy With Abraxane and 5-Fluorouracil, Epirubicin, Cyclophosphamide (FEC) for Patients With Breast Cancer

The LIFE Study: Lifestyle Interventions and Independence for Elders, Pilot

An Evaluation of Treatment of Amblyopia in Children 7 To <18 Years Old

Find Trials by Condition in Pittsburgh

ARIES - Ambrisentan in Patients With Moderate to Severe Pulmonary Arterial Hypertension (PAH)

A Phase I Study of BMS-275183 Given on a Daily Schedule in Patients With Advanced Malignancies

Depression In Juvenile Diabetics

Complications of Age-Related Macular Degeneration Prevention Trial

Study of Ipilimumab (MDX-010) Monotherapy in Patients With Previously Treated Unresectable Stage III or IV Melanoma

Study of BMS-587101 in Patients With Moderate to Severe Psoriasis

Safety and Efficacy of Avonex in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

Study of BMS-582664 in Combination With Either FOLFIRI or FOLFOX for Gastrointestinal (GI) Malignancies

A Randomized, Placebo-Controlled Trial of BMS-275291 Given Daily for 12 Months to Women With Stage 1c-IIIA Breast Cancer Receiving Adjuvant Chemotherapy and/or Hormonal Therapy

Study to Determine the Effects Treatment With Amlexanox 0.5% Oral Rinse Solution on Oral Mucositis Associated With Radiation Therapy for Cancer of the Head and Neck Region

Study Evaluating the Safety and Efficacy of CLONICEL® to Treat Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)

Rasagiline in Advanced Parkinson's Disease Patients With Motor Fluctuations Treated With Levodopa/Carbidopa Therapy.

Multicenter Study of Rasagiline in Parkinson's Disease Patients Using Levodopa and Experiencing Motor Fluctuations

A Phase I Study of BMS-275183 (Oral Taxane) Given on a Daily Schedule in Combination With Esomeprazole (Nexium) in Patients With Advanced Cancer

Herpetic Eye Disease Study (HEDS) II

Multiple Ascending Dose Study of BMS-582949 in Patients With Stable Rheumatoid Arthritis on the Methotrexate Background

Safety of Intravitreal POT-4 Therapy for Patients With Neovascular Age-Related Macular Degeneration (AMD)